Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity (original) (raw)

Cell-Based Therapy

Gene Therapy volume 7, pages 249–254 (2000)Cite this article

Abstract

We have developed a culture method for the foreign serum-free generation of highly immunostimulatory, CD83+ human dendritic cells (DC). In this study, we evaluated the feasibility and consequences of endogenously expressing antigens in mature DC using adenoviral vectors. Transduction of DC with Ad-EGFP demonstrated endogenous fluorescence in 50–85% of CD83+ DC. Ad-transduced DC stimulated the proliferation of allogeneic CD8+ and CD4+ T cells at low DC: T cell ratios. However, at high DC: T cell ratios the stimulatory capacity of Ad-transduced DC was suppressed. This immunosuppressive effect was confirmed by demonstrating that the stimulatory function of untreated DC could be suppressed in a dose-dependent manner by addition of Ad-transduced DC. Furthermore, transwell experiments suggested that direct cell contact was required. Taken together, our results demonstrate the feasibility of efficiently expressing antigens in CD83+ DC using adenoviruses. However, immunosuppressive effects must be considered and carefully studied before Ad-transduced DC are employed for clinical trials.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Banchereau J, Steinman RM . Dendritic cells and the control of immunity Nature 1998 392: 245–252
    Article CAS PubMed Google Scholar
  2. Romani N et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Meth 1996 196: 137–151
    Article CAS Google Scholar
  3. Jonuleit H et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur J Immunol 1997 27: 3135–3142
    Article CAS PubMed Google Scholar
  4. Schuler G, Steinman RM . Dendritic cells as adjuvants for immune-mediated resistance to tumors J Exp Med 1997 186: 1183–1187
    Article CAS PubMed PubMed Central Google Scholar
  5. van Elsas A et al. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen Eur J Immunol 1996 26: 1683–1689
    Article CAS PubMed Google Scholar
  6. Nestle FO et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Med 1998 4: 328–332
    Article CAS PubMed Google Scholar
  7. Tüting T, DeLeo AB, Lotze MT, Storkus WJ . Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or ‘self’ antigens induce antitumor immunity in vivo Eur J Immunol 1997 27: 2702–2707
    Article PubMed Google Scholar
  8. Specht JM et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases J Exp Med 1997 186: 1213–1221
    Article CAS PubMed PubMed Central Google Scholar
  9. Song W et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity J Exp Med 1997 186: 1247–1256
    Article CAS PubMed PubMed Central Google Scholar
  10. Wan Y et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination Hum Gene Ther 1997 8: 1355–1363
    Article CAS PubMed Google Scholar
  11. Gong J et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells Gene Therapy 1997 4: 1023–1028
    Article CAS PubMed Google Scholar
  12. Perez-Diez A et al. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene Cancer Res 1998 58: 5305–5309
    CAS PubMed Google Scholar
  13. De Veerman M et al. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity J Immunol 1999 162: 144–151
    CAS PubMed Google Scholar
  14. Arthur JF et al. A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 1997 4: 17–25
    CAS PubMed Google Scholar
  15. Labeur MS et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage J Immunol 1999 162: 168–175
    CAS PubMed Google Scholar
  16. Mackey MF et al. Dendritic cells require maturation via CD40 to generate protective antitumor immunity J Immunol 1998 161: 2094–2098
    CAS PubMed Google Scholar
  17. Brossart P et al. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte–macrophage colony-stimulating factor Blood 1998 92: 4238–4247
    CAS PubMed Google Scholar
  18. Tillman BW et al. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector J Immunol 1999 162: 6378–6383
    CAS PubMed Google Scholar
  19. Diao J et al. Human PBMC-derived dendritic cells transduced with adenovirus vector induce cytotoxic T-lymphocyte responses against vector-encoded antigen in vitro Gene Therapy 1999 6: 845–849
    Article CAS PubMed Google Scholar
  20. Hardy S et al. Construction of adenovirus vectors through Cre–lox recombination J Virol 1997 71: 1842–1849
    CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

This work was supported by grants No. SFB-432 (to AE) and Tu90/2-1 (to TT) from the Deutsche Forschungsgemeinschaft.

Author information

Author notes

  1. H Jonuleit and T Tüting: The first two authors contributed equally

Authors and Affiliations

  1. Department of Dermatology, J Gutenberg-University, Langenbeckstrasse 1, Mainz, D-55101, Germany
    H Jonuleit, T Tüting, J Steitz, J Brück, A Giesecke, K Steinbrink, J Knop & A H Enk

Authors

  1. H Jonuleit
    You can also search for this author inPubMed Google Scholar
  2. T Tüting
    You can also search for this author inPubMed Google Scholar
  3. J Steitz
    You can also search for this author inPubMed Google Scholar
  4. J Brück
    You can also search for this author inPubMed Google Scholar
  5. A Giesecke
    You can also search for this author inPubMed Google Scholar
  6. K Steinbrink
    You can also search for this author inPubMed Google Scholar
  7. J Knop
    You can also search for this author inPubMed Google Scholar
  8. A H Enk
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Jonuleit, H., Tüting, T., Steitz, J. et al. Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity.Gene Ther 7, 249–254 (2000). https://doi.org/10.1038/sj.gt.3301077

Download citation

Keywords

This article is cited by